Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Onvansertib
Onvansertib
Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy
BioSpace
Tue, 09/26/23 - 10:13 pm
Cardiff Oncology
pancreatic cancer
Onvansertib
clinical trials
Cardiff reveals early data on challenger to Amgen's KRAS crown
Fierce Biotech
Thu, 09/9/21 - 11:20 pm
Cardifff Oncology
Amgen
Onvansertib
colorectal cancer
Trovagene Receives Orphan Drug Designation for Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
CP Wire
Wed, 08/29/18 - 12:42 pm
TrovaGene
Onvansertib
AML
mCRPC
non-Hodgkin lymphoma
triple negative breast cancer